Video
23 Nov 2021

HPMC Capsules: The Other New Normal

This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme.

HPMC capsules have gained popularity in the pharmaceutical and dietary supplement markets over the past few years. There are no indications of slowing down. Why the increase from R&D through commercial products? Join this session to learn more about HPMC capsules and how they can be the proper choice for your products. See how to "Make It Better".

Why have HPMC capsules become a more popular delivery system?

  • Consumer acceptance
  • Robustness
  • Formulation
  • HPMC's involvement in complex products.
  • Content provided by our supplier

    ACG

    • IN
    • 2017
      On CPHI since
    • 4
      Certificates
    • 1000 - 4999
      Employees
    Company types
    Engineering
    Machinery and Equipment Supplier/Manufacturer
    Manufacturer/Innovator
    Packaging supplier/manufacturer
    Pharmaceutical company
    Veterinary Company
    Primary activities
    Natural Extracts
    Nutraceuticals
    Packaging & drug delivery
    Packaging materials
    Pharmaceutical Company (generic finished products)
    Pharmaceutical Company (innovator finished products)

    Other Content from ACG (5)

    • Sponsored Content How healthcare trends inform dosage forms

      Capsules encompass one of the most popular solid oral dosage forms for pharmaceutical products, with the global empty capsule market predicted to rise to USD $3.7 billion by 2026. The growth in the capsule market can be partly attributed to the many options available for drugmakers regarding capsule material, sizes, colours, and printing options. With so many options available, formulators are spoilt for choice. However, selecting the correct capsule for specific product development can lead to challenges around drug complexity and stability.  

    • Whitepaper Pharma Trends 2023

      The pharmaceutical industry has witnessed many positive developments in the last year, including 32 novel drug approvals to date, a bivalent COVID-19 vaccine, and the return of face-to-face events. However, 2022 has also presented the pharma market with new geopolitical challenges. Events such as the war in Ukraine, rising inflation, and increased energy costs have put lasting pressures on manufacturing; the effects of which are still being felt across the sector. Heading into 2023, there is an ongoing focus on the lasting impact of supply chain disruptions, and the rising costs of energy and raw materials. Sustainability also remains a mainstay in the discussion of modernising development, manufacturing, packaging, and transport practices for the pharmaceutical industry. On a positive note, innovation continues to be at the forefront of the industry, with pharmaceutical start-ups and biotechs in particular expected to bring new products, technologies and services to the traditional pharma supply chain. While 2022 has not made the transition into a new year easy, the pharmaceutical industry is in an exciting position to demonstrate its innovation, modernisation, and technological breakthroughs. ACG is proud to bring to you CPHI’s Trend Outlook for 2023, which gathers expert opinion and insights from across the pharma value chain, highlighting both emerging and continuing trends for 2023. As we enter a post-pandemic world and face new global challenges, the pharma industry must be applauded for its pursuit of new products, technologies and solutions which ultimately improve the lives of people worldwide. Read on to discover expert predictions on the trends, opportunities and challenges defining the pharma market in 2023.
    • Sponsored Content Pharma Trend Outlook: Pharma 4.0 and Industry Resilience

      Download our 2023 Pharma Trends Outlook report to discover the trends set to shape the pharmaceutical landscape in the new year, with expert opinions and insight from across the pharmaceutical value chain.
    • Whitepaper TiO2-free capsules- Market scenario in capsule development.

      US and Europe are the leaders in the healthcare market. Recently, Europe has banned the use of TiO2 as a food additive, owing to its hazardous effects. Industries are looking for the best alternatives to TiO2. What are they?
    • News ACG: Making it Better through collaboration and an integrated range of pharma and nutra products

      On the face of it, the phrase ‘Make It Better’ might seem like a clear and perhaps literal proposition to customers but as Alex Robertson, Chief Marketing Officer at ACG World explains, it holds multiple layers of meaning…